GlassScriptPhysician profile
Ashley M Bauer
NPI 1942613831
$2,620.19
in general payments reported to CMS, 2019-2025
14 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $30.26 · 2021: $490 · 2022: $395 · 2023: $551 · 2024: $880 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $829 · Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $829.49 |
| Food and Beverage | $730.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,071.95 | 2021-2024 | Everest Spinal System, Scopis Ent, Xpress Ent Dilation System |
| Genzyme Corporation | $629.37 | 2021-2025 | |
| Medtronic, INC. | $225.42 | 2021-2025 | Propel, Nuvent |
| Optinose US, INC. | $204.33 | 2023 | |
| Intersect Ent, INC. | $167.51 | 2019-2021 | |
| Inspire Medical Systems, INC. | $78.87 | 2023 | Inspire |
| Smith+Nephew, INC. | $49.40 | 2021-2022 | |
| Amgen INC. | $32.21 | 2020-2021 | |
| Sobi, INC | $31.14 | 2022 | |
| Acclarent, INC | $30.13 | 2020-2022 | |
| Aurinia Pharma U.S., INC. | $29.71 | 2021-2023 | Lupkynis |
| Integra Lifesciences Corporation | $29.68 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Alk-Abello, INC | $22.12 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.